Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • View or Listen to JNM Podcast
  • Visit JNM on Facebook
  • Join JNM on LinkedIn
  • Follow JNM on Twitter
  • Subscribe to our RSS feeds
Meeting ReportOncology: Basic, Translational & Therapy

β-adrenoceptor can influence the 18F-FDG PET imaging of breast cancer through its regulation to the posttranscriptional level of hexokinase-2

Fei Kang, Xiaowei Ma, Wenhui Ma, Yahui Shao, Liwen Li, Weidong Yang and Jing Wang
Journal of Nuclear Medicine May 2013, 54 (supplement 2) 1332;
Fei Kang
1Department of Nuclear Medicine, Xijing Hospital, Xi'an, China
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Xiaowei Ma
1Department of Nuclear Medicine, Xijing Hospital, Xi'an, China
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Wenhui Ma
1Department of Nuclear Medicine, Xijing Hospital, Xi'an, China
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Yahui Shao
1Department of Nuclear Medicine, Xijing Hospital, Xi'an, China
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Liwen Li
1Department of Nuclear Medicine, Xijing Hospital, Xi'an, China
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Weidong Yang
1Department of Nuclear Medicine, Xijing Hospital, Xi'an, China
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jing Wang
1Department of Nuclear Medicine, Xijing Hospital, Xi'an, China
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Info & Metrics
Loading

Abstract

1332

Objectives To investigate the regulation effect of the β-adrenoceptor (ADRB) activity to the levels of GLUT-1 and HK-2, which are related to the glucose uptake, and clarify its influence on the 18F-FDG PET imaging of breast cancer by microPET.

Methods The ADRB1/2 expression of the 4T1 breast cancer cell was tested by western blot (WB) and immunofluorescence. The in vitro drug intervention of ADRB was achieved by adding propranolol or isoproterenol to culture media and the regulation effect of ADRB on GLUT-1 and HK-2 was measured by WB and RT-PCR. The in vivo drug intervention was achieved by intraperitoneally injecting PBS, propranolol or isoproterenol respectively to three groups (n=6) of balb/c mice bearing 4T1 breast cancer. 18F-FDG was injected 1h later and the microPET/CT imaging was done 1h after the 18F-FDG injection. The VOIs of the tumor and the liver reference were drawn, and the T/NT value was calculated. The GLUT-1 and HK-2 in the tumors were detected by immunochemistry.

Results An abundant expression of ARDB1/2 in 4T1 breast cancer cells was identified. The in vitro study suggested that the ADRB activity was positively correlated to the expression level of HK-2 while the real-time PCR indicated that the ARDB had no significant influence to the transcriptional level of HK-2. The analysis on the in vivo imaging indicated a significantly decrease on the T/NT value of the 18F-FDG PET imaging in the propranolol treated group (p= 0.01) and a higher mean T/NT value in the isoproterenol treated group with no significant difference (5.07 vs 4.48, p=0.1783).The immunochemistry testified the in vitro result of the relationship between the pharmacological intervention and the expression levels of GLUT-1 and HK-2.

Conclusions The activity of ARDB is positively correlated to the expression level especially the posttranscriptional level of HK-2 in the 4T1 breast cancer cells. The activity of ARDB can influence the T/NT value of the 18F-FDG PET imaging of the mice bearing 4T1 breast cancer.

Previous
Back to top

In this issue

Journal of Nuclear Medicine
Vol. 54, Issue supplement 2
May 2013
  • Table of Contents
  • Index by author
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Journal of Nuclear Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
β-adrenoceptor can influence the 18F-FDG PET imaging of breast cancer through its regulation to the posttranscriptional level of hexokinase-2
(Your Name) has sent you a message from Journal of Nuclear Medicine
(Your Name) thought you would like to see the Journal of Nuclear Medicine web site.
Citation Tools
β-adrenoceptor can influence the 18F-FDG PET imaging of breast cancer through its regulation to the posttranscriptional level of hexokinase-2
Fei Kang, Xiaowei Ma, Wenhui Ma, Yahui Shao, Liwen Li, Weidong Yang, Jing Wang
Journal of Nuclear Medicine May 2013, 54 (supplement 2) 1332;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
β-adrenoceptor can influence the 18F-FDG PET imaging of breast cancer through its regulation to the posttranscriptional level of hexokinase-2
Fei Kang, Xiaowei Ma, Wenhui Ma, Yahui Shao, Liwen Li, Weidong Yang, Jing Wang
Journal of Nuclear Medicine May 2013, 54 (supplement 2) 1332;
Twitter logo Facebook logo LinkedIn logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One
Bookmark this article

Jump to section

  • Article
  • Info & Metrics

Related Articles

  • No related articles found.
  • Google Scholar

Cited By...

  • No citing articles found.
  • Google Scholar

More in this TOC Section

Oncology: Basic, Translational & Therapy

  • Lesion detection and workflow optimization in whole body diffusion MR imaging using trimodality PET/CT+MR in the oncology setting.
  • What is the impact of 18F-FDG PET/CT in the management of iodine positive metastatic differentiated thyroid cancer.
  • Analysis of the 131I therapy in the young and adolescent patients with differentiated thyroid carcinoma
Show more Oncology: Basic, Translational & Therapy

MTA I: Basic Science (Oncology) Posters

  • Therapeutic efficacy of mesenchymal stem cell expressing cytosine deaminase with prodrug 5-FC according to dihydropyrimidine dehydrogenase (DPD) expression levels in GBM
  • Axl-targeted optical imaging in lung tumor xenografts
  • Effect of mAb B3 and paclitaxel doses on accumulation and penetration of B3 into tumor
Show more MTA I: Basic Science (Oncology) Posters

Similar Articles

SNMMI

© 2025 SNMMI

Powered by HighWire